On this page · 9 sections

Daunorubicin

Generic name: daunorubicin

Brand names: Cerubidine

Last updated November 2, 2026 0 views
Share

What is daunorubicin?

Daunorubicin is used in combination with other drugs to treat leukemia.

Daunorubicin may also be used for reasons not mentioned in this medication guide.

This section was rewritten for readability and reviewed for meaning.

Warnings

Daunorubicin may harm your heart and can also raise your chance of bleeding or getting an infection. Contact your doctor immediately if you experience chest pain, shortness of breath, swelling or quick weight gain, fever, chills, fatigue, easy bruising, or unusual bleeding.

This section was rewritten for readability and reviewed for meaning.

Before taking this medicine

You should not use daunorubicin if you are allergic to it.

Tell your doctor if you have ever had:

  • heart disease;
  • kidney disease;
  • liver disease;
  • a weak immune system (caused by disease or by using certain medicines); or
  • if you have ever been treated with doxorubicin, epirubicin, idarubicin, mitoxantrone, or liposomal daunorubicin (Daunoxome).

Using daunorubicin may increase your risk of developing other types of leukemia. Ask your doctor about your specific risk.

Daunorubicin may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.

You should not breastfeed while using daunorubicin.

This section was rewritten for readability and reviewed for meaning.

Daunorubicin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Daunorubicin may cause serious side effects. Call your doctor right away if you have:

  • pain, burning, irritation, or changes in the skin where the injection was given;
  • heart problems—swelling, rapid weight gain, feeling short of breath;
  • low blood cell counts—fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed;
  • kidney problems—little or no urination, swelling in your feet or ankles, feeling tired; or
  • liver problems—loss of appetite, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Common side effects of daunorubicin may include:

  • sores or white patches in or around your mouth, trouble swallowing or talking, dry mouth, bad breath, altered sense of taste;
  • red discoloration of the urine;
  • nausea, vomiting; or
  • hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This section was rewritten for readability and reviewed for meaning.

How should I use daunorubicin?

Daunorubicin is given as an infusion into a vein. A healthcare provider will give you this injection.

Before you receive each dose of daunorubicin, your heart function may need to be checked with an electrocardiograph or ECG (sometimes called an EKG). Your kidney and liver function may also need to be checked.

You may be given other medications to help prevent serious side effects or an allergic reaction. Keep using these medicines for as long as your doctor has prescribed.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when daunorubicin is injected.

Skin accidentally exposed to daunorubicin should be rinsed thoroughly with soap and warm water.

Daunorubicin can increase your risk of bleeding or infection. You will need frequent medical tests. Your cancer treatments may be delayed based on the results of these tests.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your daunorubicin injection.

This section was rewritten for readability and reviewed for meaning.

What happens if I overdose?

Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to happen.

Avoid being near people who are sick or have infections. Tell your doctor immediately if you develop signs of infection.

This section was rewritten for readability and reviewed for meaning.

What other drugs will affect daunorubicin?

Daunorubicin can damage your liver, particularly if you are also taking certain medications for infections, tuberculosis, birth control, hormone replacement, high cholesterol, heart issues, high blood pressure, seizures, pain, or arthritis (including Tylenol, Advil, Motrin, or Aleve).

Other medications may impact daunorubicin, including prescription and over-the-counter drugs, vitamins, and herbal products. Inform your doctor about all the medicines you are currently using and any new medicines you begin or stop using.

This section was rewritten for readability and reviewed for meaning.

Common questions about daunorubicin

How soon will my hair grow back after chemotherapy?
After finishing chemotherapy, some may notice fine, soft hair appearing as early as 3 to 6 weeks after treatment ends. It can take several months for your hair to return to its previous length and thickness. Continue reading
How soon can you start chemo after port placement?
Chemotherapy can typically begin within a few days to 2 weeks after port placement, depending on factors like healing progress and treatment urgency. Continue reading
Will I lose my hair during chemotherapy treatment?
Chemotherapy-induced hair loss is common and usually temporary, caused by the drugs targeting rapidly dividing hair follicle cells. Hair loss typically starts a few weeks after treatment begins and regrows a few months after it ends. Continue reading

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language

Content is provided for education and is not medical advice. See our medical disclaimer.